Recent Posts on This Topic | See All >
New Board Members at at Apthera, IncTags: cancer
[Source: Marketwire] - Apthera, Inc. ("Apthera") today announced the appointments of Mr. Ira Z. Leiderman and Dr. Mary Ann Gray to the Apthera Board as independent directors and the appointment of Mr. Leiderman as its Executive Chairman.
"Apthera made a commitment to build an outstanding independent board that will accelerate the development of Apthera and its lead product, NeuVax™, an active specific immunotherapy for early-stage breast cancer. Ira's prior relationship with the Company, along with his extensive life sciences industry knowledge and relationships, uniquely qualified him to assist the Company in meeting its objectives," said Dr. Joseph Sinkule, Co-founder and Chief Scientific Officer of Apthera.
“Arizona’s Bioscience Roadmap 2014-2025: Advancing the Biosciences and Improving Health Outcomes,” is available along with its supplement, “Summary of Goals, Strategies, and Potential Actions.” The updated Roadmap provides a long-term strategy for Arizona to achieve bioscience success over the next decade. Also, discover The State of Bioscience.